Calcipotriol/Betamethasone Ointment and Gel

Calcipotriol/betamethasone dipropionate ointment and gel are topical combination medications specifically formulated for the treatment of plaque psoriasis in adults aged 18 years and older. These products combine a vitamin D analogue with a potent corticosteroid to address both the scaling and inflammation associated with psoriasis plaques on the body, trunk, limbs, and scalp.

Introduction

Plaque psoriasis, also known as psoriasis vulgaris, is a chronic inflammatory skin condition characterized by well-demarcated, erythematous plaques covered with silvery scales. It affects approximately 2-3% of the global population and significantly impacts quality of life due to itchiness, pain, and cosmetic concerns. Topical therapies remain the first-line treatment for mild to moderate cases, particularly when lesions are limited to less than 10% of the body surface area.

Calcipotriol/betamethasone dipropionate represents a fixed-dose combination that leverages the synergistic effects of its two active ingredients. Available as an ointment (e.g., Daivobet, Dovobet) for body plaques and a gel (e.g., Xamiol) optimized for scalp and hairy areas, this therapy offers convenient once-daily application. Clinical trials involving over 2,500 patients have demonstrated superior efficacy compared to monotherapy with either component or placebo.

Psoriasis Overview

Psoriasis arises from an interplay of genetic predisposition, immune dysregulation, and environmental triggers. T-cells infiltrate the skin, releasing cytokines that drive keratinocyte hyperproliferation, incomplete differentiation, and angiogenesis. This results in thickened epidermis, parakeratosis, and Munro microabscesses visible on histopathology. Plaque psoriasis typically presents on extensor surfaces, scalp, nails, and sacral areas.

Symptoms include pruritus, burning, and joint involvement in up to 30% of cases (psoriatic arthritis). Triggers encompass stress, infections (e.g., streptococcal), trauma (Koebner phenomenon), alcohol, smoking, and medications like beta-blockers or lithium. Effective management requires reducing plaque severity, measured by tools like the Psoriasis Area and Severity Index (PASI).

How It Works

The dual mechanism targets key pathological features of psoriasis. Calcipotriol, a synthetic vitamin D3 analogue (calcipotriene), binds to vitamin D receptors in keratinocytes, inhibiting hyperproliferation, promoting differentiation, and suppressing cytokine production (e.g., IL-2, IL-8, IL-17). It normalizes skin cell growth rates from the psoriatic 28-fold increase to near-normal levels.

Betamethasone dipropionate, a group III corticosteroid, exerts anti-inflammatory effects by activating glucocorticoid receptors, inhibiting phospholipase A2, reducing arachidonic acid derivatives (prostaglandins, leukotrienes), and downregulating pro-inflammatory cytokines (TNF-α, IL-23). The combination yields faster clearance than monotherapies: in trials, 70-80% of patients achieved clear/almost clear skin after 4 weeks versus 40-50% with components alone.

Each gram contains 50 mcg calcipotriol and 500 mcg (0.5 mg) betamethasone dipropionate, ensuring balanced potency without excessive steroid exposure.

How to Use

Apply once daily to affected areas, using no more than 15 g daily or 100 g weekly to minimize systemic absorption risks. For ointment, spread thinly on clean, dry plaques of trunk/limbs; avoid face, genitals, or intertriginous areas unless directed.

Gel is ideal for scalp psoriasis: shake tube, part hair, apply 1-4 g (up to 1 teaspoon) directly to plaques, rub gently. Do not wash hair immediately; leave on overnight or all day for optimal penetration through hair shafts. Suitable for hairy body areas too.

• Shake tube before use.
• Wash hands after application (unless treating hands).
• If dose missed, apply ASAP; skip if near next dose—never double.
• Do not cover with bandages unless advised (occlusion increases absorption).

Treatment duration: 4 weeks standard; extend to 8 weeks on body under supervision if responding. Maintenance: use as-needed post-clearance.

How Long to Use

Initial course: 4 weeks for ointment, up to 8 weeks for gel on body/scalp. Response typically evident within 1-2 weeks; full clearance in 50-70% by week 4. Discontinue upon improvement; restart intermittent courses (e.g., twice weekly) for relapse prevention, as supported by long-term studies showing sustained remission.

Exceeding 8 weeks risks tachyphylaxis (steroid tolerance) or rebound flares. Physician monitoring via PASI scores guides extension.

Contraindications

Absolute contraindications include:

• Hypersensitivity to calcipotriol, betamethasone, or excipients (e.g., propylene carbonate in gel).
• Calcium metabolism disorders (hypercalcemia, hypercalciuria).
• Severe psoriasis types: erythrodermic, generalized pustular, or exfoliative.
• Viral skin infections (herpes simplex, varicella), fungal (tinea), bacterial, or parasitic infections at site.
• Perioral dermatitis, acne, rosacea, thin skin, striae, ichthyosis.

Warnings and Precautions

Limit to ≤30% body surface area to prevent hypercalcemia from calcipotriol absorption. Monitor serum calcium if large areas treated or doses exceeded. Avoid eyes/mucous membranes; rinse if contact occurs. Steroid precautions: watch for skin atrophy, telangiectasia with prolonged use.

Pregnancy: Category C; use only if benefits outweigh risks (minimal systemic absorption). Lactation: avoid breast application to prevent infant ingestion. Sunlight: may increase irritation; use sunscreen.

Use in Specific Populations

Pediatrics: Not recommended under 18 years due to insufficient safety/efficacy data; steroid risks higher in children.

Pregnancy/Breastfeeding: Limited data; animal studies show no teratogenicity, but use cautiously. Wipe off breasts before nursing.

Elderly/Renal-Hepatic Impairment: No dose adjustment needed; monitor for steroid effects.

Potential Drug Interactions

• Avoid concurrent calcium/vitamin D supplements (risk hypercalcemia).
• Drugs increasing calcium absorption (e.g., thiazides).
• Systemic steroids or other topicals: monitor cumulative steroid load.
• No significant interactions with oral meds due to low systemic exposure.

Possible Side Effects

Overall, 10% experience mild effects; most application-site related. Common (>1/10): pruritus, skin irritation/exfoliation.

Serious: rare anaphylaxis, rebound psoriasis on discontinuation. Report persistent effects to physician.

Pharmacological Class-Associated Adverse Effects

Vitamin D analogue: hypercalcemia/hypercalciuria (dose-dependent; resolves on cessation). Corticosteroid: local (atrophy, striae, purpura) > systemic (HPA suppression rare <100g/week). Long-term: glaucoma risk if periorbital.

Frequently Asked Questions (FAQs)

Q: Can I use this on my face or genitals?

A: No, unless specifically prescribed; high absorption risks steroid side effects.

Q: How much gel for scalp?

A: 1-4g daily (1 teaspoon max); rub into plaques.

Q: What if I overdose?

A: Seek medical advice; monitor calcium levels.

Q: Is it safe for long-term use?

A: Up to 8 weeks; intermittent thereafter to prevent tolerance.

Q: Does it cure psoriasis?

A: Controls symptoms; psoriasis is chronic.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete